| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX009 (ip) | median survival time | other | 6.25 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 30; 07/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 12.5 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 25.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 50.0 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 100.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 30; 06/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 200.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |